Canterbury Scientific Ltd is a New Zealand medical device company that was founded out of the Canterbury District Health Board (CDHB) in 1985 by directors Professor Robin Carrell, Bryce Hawkins, and Dr Maurice Owen.
Helping people with diabetes – HbA1C control
Innovative hemoglobin controls have been developed for major international clients from the USA, Europe and Japan. Our top seller, the hemoglobin A1c control, is today depended on by a significant proportion of the global diabetic population to assist in maintaining their glucose levels.
Canterbury Scientific is the only company in the world that can make the level 2 diabetic HbA1c control by in vitro glycation instead of using blood from diabetic subjects whose glucose levels are not well controlled.
Canterbury Scientific today is a thriving company as a result of our quality products that compete with the best in the world. Some key points of difference include individual technical service and supply, knowledgeable support, a first-class research and development team headed by internationally respected scientists, and state-of-the-art laboratories designed to meet the most stringent of international quality standards.
Our facility at 71 Whiteleigh Ave, Christchurch, New Zealand has been specially furbished with modern and highly sophisticated systems, including precise temperature and humidity control, to provide an advanced and sustainable environment that meets world-class current manufacturing practices. The building was opened on 18 February, 2011 by the Hon Dr Wayne Mapp, New Zealand Government Minister for Science and Innovation.
Furthering science innovation through collaboration
Canterbury Scientific continues to move ahead into the wider field of medical biotechnology and aims to broaden and widen its range of products. We are committed to opening career opportunities for New Zealand’s top graduates, and to broadening the strength of medical science in New Zealand, and in Christchurch in particular.
To achieve this, the company sees huge importance and value in nurturing close relations with academic and research based organisations including Canterbury DHB, Canterbury Health Laboratories, University of Otago, Christchurch (School of Medicine), Cambridge University in the UK and the Biomolecular Interaction Centre at Canterbury University (with linkages to the University of Otago, Lincoln University, Callaghan Innovation’s Carbohydrate Chemistry group, Fonterra and others).
Canterbury Scientific contributes to both international conferences (including the International Symposium on the Chemistry and Biology of Serpins) and local charities that work to improve scientific research and education, and improve the well-being of our community.
Canterbury Scientific has been recognised in a number of awards programs for its innovation and export achievements. These include:
KiwiNet Awards 2016 – Finalist
NZ Bio Awards 2015 – Finalist
Champion Canterbury Awards 2012 – Winner of the Global Operator and Supreme Awards
New Zealand Innovators Awards 2012 – Winner of Health and Science category
TIN100+ 2011 & 2012 annual ranking of the fastest growing New Zealand technology companies.